Biomedical Advanced Research and Development Authority
COVID-19 Vaccines: Moderna declares successful trial results after Pfizer
The new vaccine candidate by Moderna Inc, called mRNA-1273, has reportedly shown 94.5% efficacy against the SARS-CoV-2 in the phase III clinical trials
- Israeli massacres, settler violence surge in Gaza and West Bank
- Israel continues to target Palestinian and foreign journalists
- Argentine Chamber of Deputies ratifies Milei’s veto of university funding law
- Israel commits new massacre in Damascus, continues attacks on Lebanon and Gaza
- Undercover Israeli forces kill four Palestinians in Nablus
